Michael Ryskin Stock Analyst Profile - B of A Securities Research Coverage - Stocknear

Michael Ryskin

Stock Analyst at B of A Securities

(3.01)
# 2959
Out of 5,459 analysts
46
Total ratings
Success rate
Average return
16 Stocks
Name Action PT Current % Upside Ratings Updated
TEM Tempus AI
Maintains: Neutral
68 70
73.21 -4.38% 6 Jun 25, 2025
IDXX IDEXX Laboratories
Maintains: Neutral
535 475
640.86 -25.88% 3 Apr 21, 2025
MRVI Maravai LifeSciences
Maintains: Buy
9 8
2.33 243.35% 3 Mar 3, 2025
ALGN Align Tech
Maintains: Underperform
200 206
141.98 45.09% 6 Dec 13, 2024
GH Guardant Health
Maintains: Strong Buy
28 40
63.5 -37.01% 1 Jul 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 10
3.9 143.59% 1 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
11 9
n/a n/a 2 Jan 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
27 24
10.97 118.78% 2 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
27 24
13.2 81.82% 2 Jul 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
25
23.99 4.21% 2 Jun 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
225 180
155.41 15.82% 7 Nov 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
90
20.01 349.78% 3 Aug 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Apr 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
80 52
19.79 162.76% 2 Nov 11, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
17 10
2.55 292.16% 2 Nov 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
10 7
n/a n/a 2 May 14, 2020